Home / Expertise / Corporate / M&A

Corporate / M&A

Switzerland

Whether you are planning a merger as part of your growth strategy, thinking about diversifying into new sectors or looking for new funding options such as non-bank lending or through equity investment, our experts offer you the right mix of legal and commercial advice. Having lawyers who think and act beyond their traditional role and seek to add value can help you secure the competitive edge you need in an ever-changing business environment. Our international team of more than 700 corporate lawyers in 43 countries worldwide can assist you in all aspects of corporate law and M&A, both domestically and internationally.

Whatever your size, a large publicly listed company or a small privately owned business, we can deliver a tailored, commercial, cost effective solution for you, covering areas such as M&A, private equity, equity capital markets, outsourcing, group restructuring and privatisations. Our cross-border teams consist of experts from all practice areas and sectors such as banking, consumer products, energy, infrastructure, insurance, lifesciences, real estate and construction, hotels and leisure, technology and media. This allows us to understand your specific issues for a transaction and provide you with advice within context, saving time and money and allows us to pinpoint your real commercial issues and risks in a transaction.

Read more Read less

Feed

13/07/2021
CMS ad­vised HEB on the di­vest­ment of its stake in SIX lis­ted Cicor to One...
Zurich, 19 Ju­ly 2021 | HEB Swiss In­vest­ment AG, a Zurich-based hold­ing com­pany owned by a Ger­man private in­vestor, has entered in­to an agree­ment to sell its ma­jor stake (29.3 %) in lis­ted Cicor Tech­no­lo­gies...
13/07/2021
Pro­posed ac­quis­i­tion of Air Europa by IAG: Com­mis­sion opens in-depth in­vest­ig­a­tion
On 29 June 2021, the European Com­mis­sion opened Phase II mer­ger con­trol pro­ceed­ings on IAG's pro­posed ac­quis­i­tion of Air Europa be­cause of its po­ten­tial im­pact on the Span­ish air ser­vices mar­ket. In May...
30/06/2021
EU Na­tion­al Com­pet­i­tion Au­thor­it­ies pub­lish joint pa­per on Di­git­al Mar­kets...
The de­bate about the draft Di­git­al Mar­kets Act (DMA) – the European Com­mis­sion's flag­ship pro­ject in the di­git­al sec­tor – is in­tensi­fy­ing. In May, the self-pro­claimed "Friends of an Ef­fect­ive DMA"...
07/06/2021
CMS ad­vised CCC Group on the sale of Vögele Shoes
A team of CMS Zurich led by Stefan Brunnsch­weiler ad­vised CCC Group on all leg­al as­pects of the sale of Vögele Shoes - a tra­di­tion­al brand in the Swiss shoe trade that is cel­eb­rat­ing its 100th an­niversary...
01/06/2021
Some leaks can­'t be fixed
“Con­fid­en­tial in­form­a­tion is like an ice cube... give it to the party who has no re­fri­ger­at­or or will not agree to keep it in one, and by the time of the tri­al you have just a pool of wa­ter.” This...
28/05/2021
“Friends of an ef­fect­ive Di­git­al Mar­kets Act” – France, Ger­many and Neth­er­lands...
On 27-28 May 2021, EU pres­id­ency in­formed mem­ber states at the EU Com­pet­it­ive­ness Coun­cil on pro­gress achieved so far on the Com­mis­sion’s pro­pos­als for a Di­git­al Ser­vices Act (DSA) and a Di­git­al Mar­kets...
25/05/2021
CMS ad­vised Nahrin on the ac­quis­i­tion of Swis­s­care SRL
Zurich – A team of CMS Switzer­land and CMS Italy led by Stefan Brunnsch­weiler ad­vised Nahrin on all leg­al as­pects of the ac­quis­i­tion of the in Italy based Swis­s­care SRL from Alcedo IV and the two found­ing...
10/05/2021
Vi­ol­a­tion of mer­ger con­trol pro­ced­ur­al rules: European Com­mis­sion fines...
On 3 May 2021, the European Com­mis­sion fined chem­ic­al maker Sigma-Ald­rich EUR 7.5 mil­lion for provid­ing mis­lead­ing in­form­a­tion dur­ing mer­ger con­trol pro­ceed­ings for Sigma-Ald­rich’s takeover by rival...
04/05/2021
With Il­lu­mina ac­tion, court to test EU Com­mis­sion's new mer­ger re­fer­ral...
On 29 April 2021, the US life sci­ences com­pany Il­lu­mina con­firmed that it filed an ac­tion be­fore the EU courts ask­ing for an an­nul­ment of the European Com­mis­sion’s de­cision of 19 April 2021 to ac­cept...
29/04/2021
CMS in 27 areas of law one of the "Top Law Firms" in Switzer­land
CMS once again one of the lead­ing law firms in Switzer­land For the fifth time, the lead­ing Swiss busi­ness magazine BIL­ANZ and news­pa­per Le Temps have pub­lished their rank­ing of the best law firms...
27/04/2021
The Fed­er­al Su­preme Court's judg­ment in the mat­ter "Hors-Liste Medika­mente...
On 21 April 2021, the Fed­er­al Su­preme Court pub­lished a judg­ment against Pf­izer re­gard­ing the sanc­tion or­der of the Com­pet­i­tion Com­mis­sion (COMCO) in the mat­ter Hors-Liste Medika­mente (Pre­isem­p­fehlun­gen)...
19/04/2021
CMS ad­vises on the sale of ra­dio-onko­lo­gie amsler ag
Zurich, 16 April 2021 | BAM­CAM Hold­ing AG sold all shares in ra­dio-onko­lo­gie amsler ag to stock ex­change lis­ted Atrys Health Group. Foun­ded in 2003, ra­dio-onko­lo­gie amsler ag today is one of the main...